News
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
12 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Cassava Sciences Completes Interim Safety Review Of Oral Simufilam On-Going Phase 3 Trials
25 Mar 24
Biotech, News, General
(SAVA) - Analyzing Cassava Sciences's Short Interest
21 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report
11 Mar 24
News, Health Care
Boeing, Oracle, Meta Platforms, Cassava Sciences, Tesla: Why These 5 Stocks Are On Investors' Radars Today
11 Mar 24
Cryptocurrency, News, Markets
HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Cassava Sciences: Q4 Earnings Insights
28 Feb 24
Earnings
Cassava Sciences Q4 EPS $(0.50) Beats $(0.52) Estimate
28 Feb 24
Earnings, Earnings Beats, News
Why Alzheimers-Drug Developer Cassava Sciences Stock Is Trending
7 Feb 24
Biotech, News, Movers & Shakers, General
Cassava Sciences Reports Top-Line Results Of Two-Year Clinical Safety Study Of Simufilam, Investigational Oral Drug For Treatment Of Alzheimer's Disease
7 Feb 24
Biotech, News, General
(SAVA) - Analyzing Cassava Sciences's Short Interest
29 Jan 24
Short Sellers, Short Ideas, Trading Ideas
Press releases
Redemption Date Announced for Warrants
15 Apr 24
Press Releases
CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
5 Apr 24
News, Legal, Press Releases
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the Firm
2 Apr 24
News, Legal, Press Releases
Cassava Sciences, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 2, 2024 deadline.
1 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA
31 Mar 24
News, Legal, Press Releases
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action – SAVA
31 Mar 24
News, Legal, Press Releases
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
31 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
29 Mar 24
Press Releases
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
28 Mar 24
News, Legal, Press Releases
ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
27 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
27 Mar 24
Press Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm
25 Mar 24
News, Legal, Press Releases
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
25 Mar 24
Press Releases
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action – SAVA
24 Mar 24
News, Legal, Press Releases
SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
24 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA
23 Mar 24
News, Legal, Press Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm
21 Mar 24
News, Legal, Press Releases
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava
21 Mar 24
Press Releases
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
20 Mar 24
Press Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm
17 Mar 24
News, Legal, Press Releases